A Comparison of Sustained-Release Bupropion and Placebo for Smoking Cessation

Pharmacologic treatments such as nicotine-replacement therapy have been shown to help smokers stop smoking. Using a medication that does not contain nicotine, such as an antidepressant, has intrigued investigators for several reasons. Smokers are more likely to have a history of major depression tha...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The New England journal of medicine 1997-10, Vol.337 (17), p.1195-1202
Hauptverfasser: Hurt, Richard D, Sachs, David P.L, Glover, Penny N, Glover, Elbert D, Offord, Kenneth P, Johnston, J. Andrew, Dale, Lowell C, Khayrallah, Moise A, Schroeder, Darrell R, Sullivan, C. Rollynn, Sullivan, Pamela M, Croghan, Ivana T
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Pharmacologic treatments such as nicotine-replacement therapy have been shown to help smokers stop smoking. Using a medication that does not contain nicotine, such as an antidepressant, has intrigued investigators for several reasons. Smokers are more likely to have a history of major depression than nonsmokers, 1 , 2 and nicotine may act as an antidepressant in some smokers. 3 , 4 The development of a depressed affect or depression after smoking cessation may lead to relapse. 5 – 7 Results of clinical trials of antidepressant therapy for smoking cessation have been mixed. The initial experience with doxepin was promising; however, no large trials have been reported. . . .
ISSN:0028-4793
1533-4406
DOI:10.1056/NEJM199710233371703